Log In
Print
BCIQ
Print
Print this Print this
 

Imgatuzumab (GA201, RO5083945) (RG7160)

  Manage Alerts
Collapse Summary General Information
Company Roche
DescriptionHumanized mAb against EGFR
Molecular Target Epidermal growth factor receptor (EGFR)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase I/II
Standard IndicationNon-small cell lung cancer (NSCLC)
Indication DetailsTreat metastatic non-small cell lung cancer (NSCLC)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today